Tirzepatide is primarily indicated for the treatment of T2D and is expected to receive its decision from the FDA in Q2 2022
Q1 net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter
The pharma companies will bring quality products at competitive prices to consumers in Oman and help bring down the cost of healthcare
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
An Integrated programme comprising GOQii device, Glucometer – Contour Plus+1 from Ascensia Diabetes Care India and personalised diabetes coaching
A centralised kitchen which provides 5,000 breakfast meals per day is to be started at Perumallapuram, Kakinada, Andhra Pradesh
Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities
Subscribe To Our Newsletter & Stay Updated
